Patent details
EP3697818
Title:
TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB
Basic Information
- Publication number:
- EP3697818
- PCT Application Number:
- JP2018038924
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP188047203
- PCT Publication Number:
- WO2019017499
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB
- French Title of Invention:
- TRAITEMENT DU LYMPHOME À CELLULES B CD20-POSITIVES PAR L'OBINUTUZUMAB
- German Title of Invention:
- BEHANDLUNG VON CD20-POSITIVEM B-ZELL-LYMPHOM MIT OBINUTUZUMAB
- SPC Number:
-
Dates
- Filing date:
- 19/10/2018
- Grant date:
- 27/11/2024
- EP Publication Date:
- 26/08/2020
- PCT Publication Date:
- 24/01/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/11/2024
- EP B1 Publication Date:
- 27/11/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/10/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/11/2024
-
-
- Name:
- F. Hoffmann-La Roche AG
- Address:
- Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)
Inventor
1
- Name:
- LIN, Chin-Yu
- Address:
- United States (US)
2
- Name:
- MOBASHER, Mehrdad
- Address:
- United States (US)
3
- Name:
- WENGER, Michael
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 201762574297 P
- Priority Date:
- 19/10/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
C07K 16/28;
A61P 35/00;
A61K 39/395;
Publication
European Patent Bulletin
1
- Issue number:
- 202448
- Publication date:
- 27/11/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202452
- Publication date:
- 25/12/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |